Mineral and bone disorder and its association with cardiovascular parameters in chinese patients with chronic kidney disease

Chinese Medical Journal

Volumn 129, Issue 19, 2016, Pages 2275-2280

  Zhou, Chu ^a,b   Wang, Fang ^a   Wang, Jin Wei ^a   Zhang, Lu Xia ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chronic kidney disease; Hyperphosphatemia; Left ventricular hypertrophy; Mineral and bone disorder; Vascular calcification

Indexed keywords

SERUM ALBUMIN; PHOSPHORUS;

ABDOMINAL AORTIC CALCIFICATION; ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; BONE DISEASE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHINESE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERPHOSPHATEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PROSPECTIVE STUDY; SPECTROPHOTOMETRY; ADOLESCENT; BLOOD; BLOOD VESSEL CALCIFICATION; CHINA; CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; GLOMERULUS FILTRATION RATE; METABOLISM; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHINA; CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERPHOSPHATEMIA; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; PHOSPHORUS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; VASCULAR CALCIFICATION; YOUNG ADULT;

EID: 84987881650     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.190678     Document Type: Article

References (26)

1. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 2012;379:815-22. doi: 10.1016/S0140-6736(12)60033-6.
2. Bansal N, Lin F, Vittinghoff E, Peralta C, Lima J, Kramer H, et al. Estimated GFR and subsequent higher left ventricular mass in young and middle-aged adults with normal kidney function: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Kidney Dis 2016;67:227-34. doi: 10.1053/jajkd.2015.06.024.
3. Chia YC, Lim HM, Ching SM. Use of chronic kidney disease to enhance prediction of cardiovascular risk in those at medium risk. PLoS One 2015;10:e0141344. doi: 10.1371/journal.pone.0141344.
4. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42 4 Suppl 3:S1-201. doi: 10.1016/S0272-6386(03)00905-3.
5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1-130. doi: 10.1038/ki.2009.188.
6. Yao L, Sun YT, Sun W, Xu TH, Ren C, Fan X, et al. High phosphorus level leads to aortic calcification via ß-catenin in chronic kidney disease. Am J Nephrol 2015;41:28-36. doi: 10.1159/000370250.
7. Kendrick J, Chonchol M. The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis 2011;58:826-34. doi: 10.1053/j.ajkd.2011.07.020.
8. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011;121:4393-408. doi: 10.1172/JCI46122.
9. Gao B, Zhang L, Wang H, Zhao M. Chinese Cohort Study of Chronic Kidney Disease: Design and methods. Chin Med J 2014;127:2180-5. doi: 10.3760/cma.j.issn.0366-6999.20132906.
10. Andrassy KM. Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease’. Kidney Int 2013;84:622-3. doi: 10.1038/ki.2013.243.
11. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006;17:2937-44. doi: 10.1681/ASN.2006040368.
12. Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: A 25-year follow-up study. Atherosclerosis 1997;132:245-50. doi: 10.1016/S00219150(97)00106-8.
13. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-8. doi: 10.1016/0002-9149(86)90771-X.
14. Vassalotti JA, Uribarri J, Chen SC, Li S, Wang C, Collins AJ, et al. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008;51 4 Suppl 2:S56-68. doi: 10.1053/j.ajkd.2007.12.018.
15. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, et al. Chronic Renal Insufficiency Cohort (CRIC) Study: Baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 2009;4:1302-11. doi: 10.2215/CJN.00070109.
16. Gallieni M, De Luca N, Santoro D, Meneghel G, Formica M, Grandaliano G, et al. Management of CKD-MBD in non-dialysis patients under regular nephrology care: A prospective multicenter study. J Nephrol 2016;29:71-8. doi: 10.1007/s40620-015-0202-4.
17. Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, et al. Chronic Kidney Disease Japan Cohort study: Baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol 2010;14:558-70. doi: 10.1007/s10157-010-0328-6
18. Hamano T, Fujii N, Matsui I, Nakano C, Inoue K, Tomida K, et al. Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in Japan. Ther Apher Dial 2011;15 Suppl 1:2-8. doi: 10.1111/j.1744-9987.2011.00918.x.
19. Bellasi A, Ferramosca E, Muntner P, Ratti C, Wildman RP, Block GA, et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int 2006;70:1623-8. doi: 10.1038/sj.ki.5001820.
20. Craver L, Dusso A, Martinez-Alonso M, Sarro F, Valdivielso JM, Fernández E. A low fractional excretion of phosphate/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients. BMC Nephrol 2013;14:221. doi: 10.1186/1471-2369-14-221.
21. Wang M, Wang M, Lu L, Yang B, Li S, Zhang M. Arterial stiffness and associated factors in non-diabetic pre-dialysis patients with chronic kidney disease. Chin J Nephrol 2009;25:277-81. doi: 10.3760/cma. j.issn.1001-7097.2009.04.007.
22. Dhingra R, Gona P, Benjamin EJ, Wang TJ,Aragam J, D’Agostino RB Sr., et al. Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community. Eur J Heart Fail 2010;12:812-8. doi: 10.1093/eurjhf/hfq106.
23. Selamet U, Tighiouart H, Sarnak MJ, Beck G, Levey AS, Block G, et al. Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study. Kidney Int 2016;89:176-84. doi: 10.1038/ki.2015.284.
24. Chue CD, Edwards NC, Moody WE, Steeds RP, Townend JN, Ferro CJ. Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: A cardiac magnetic resonance study. Heart 2012;98:219-24. doi: 10.1136/heartjnl-2011-300570.
25. Wang J, Wang F, Dong S, Zeng Q, Zhang L. Levels of serum phosphorus and cardiovascular surrogate markers. J Atheroscler Thromb 2016;23:95-104. doi: 10.5551/jat.31153.
26. Nakamura H, Tokumoto M, Mizobuchi M, Ritter CS, Finch JL, Mukai M, et al. Novel markers of left ventricular hypertrophy in uremia. Am J Nephrol 2010;31:292-302. doi: 10.1159/000279768.